HLB

Google News EN

HLB nears FDA approval for bile duct cancer drug after smooth final review - CHOSUNBIZ - Chosunbiz

07/24/2026, 08:51 GMT+9

Google News EN

VAI rating resets HLB liver cancer drug bid but four hurdles loom - CHOSUNBIZ - Chosunbiz

07/24/2026, 06:21 GMT+9

Google News EN

HLB Unit Immunomic Doses First Patient in U.S. Phase 1 Cancer Vaccine Trial - Seoul Economic Daily

07/20/2026, 09:33 GMT+9

Google News EN

HLB's Liver Cancer Drug Clears FDA Manufacturing Hurdle; Group Stocks Surge for Second Day - finance.biggo.com

07/16/2026, 16:06 GMT+9

Google News EN Broad

HLB Shakes Off 'Limit-Down Nightmare' as 8 Group Stocks Hit Ceiling - Seoul Economic Daily

07/15/2026, 13:54 GMT+9

Google News EN

HLB Says Key Cause of Liver Cancer Drug CRL Resolved as FDA Classifies Chinese API Plant Inspection as VAI; Group Shares Surge - finance.biggo.com

07/15/2026, 10:45 GMT+9

Google News EN

HLB Secures FDA Inspection Findings, Formally Launches Re-application for Liver Cancer Drug - finance.biggo.com

07/14/2026, 00:36 GMT+9

Google News EN Broad

As HLB's stock price plunged due to unfavorable factors related to new drugs, the market capitalizat.. - 매일경제

07/13/2026, 16:00 GMT+9

Google News EN

HLB and Peptron Hit Daily Limit Down in Tandem — A Trigger for a K-Bio Trust Crisis? - finance.biggo.com

07/12/2026, 16:55 GMT+9

Google News EN Broad

HLB group stocks sink in South Korea after FDA rejects liver cancer drug - CHOSUNBIZ - Chosunbiz

07/10/2026, 16:00 GMT+9

Google News EN

HLB Plunges to Daily Limit as FDA Issues Third Rejection for Liver Cancer Drug; Group Stocks Wiped Out - finance.biggo.com

07/09/2026, 16:00 GMT+9

Google News EN

HLB Moves to Calm Stock Slide Ahead of FDA Decision - Seoul Economic Daily

06/11/2026, 16:00 GMT+9

Google News EN Broad

BlackRock takes 5% stake in HLB amid FDA review - The Korea Herald

03/04/2026, 17:00 GMT+9

Google News EN Broad

Investors dump Korean biotech HLB stocks on FDA rejection - KED Global

05/17/2024, 16:00 GMT+9